These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33781276)

  • 1. Viscoelastic properties of white and gray matter-derived microglia differentiate upon treatment with lipopolysaccharide but not upon treatment with myelin.
    van Wageningen TA; Antonovaite N; Paardekam E; Brevé JJP; Iannuzzi D; van Dam AM
    J Neuroinflammation; 2021 Mar; 18(1):83. PubMed ID: 33781276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic indentation reveals differential viscoelastic properties of white matter versus gray matter-derived astrocytes upon treatment with lipopolysaccharide.
    Antonovaite N; van Wageningen TA; Paardekam EJ; van Dam AM; Iannuzzi D
    J Mech Behav Biomed Mater; 2020 Sep; 109():103783. PubMed ID: 32543389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
    Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
    Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain.
    Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F; Agresti C
    Front Cell Neurosci; 2020; 14():190. PubMed ID: 32733206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination.
    Lentferink DH; Jongsma JM; Werkman I; Baron W
    Sci Rep; 2018 Feb; 8(1):2113. PubMed ID: 29391408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional heterogeneity between primary adult grey and white matter astrocytes underlie differences in modulation of in vitro myelination.
    Werkman IL; Dubbelaar ML; van der Vlies P; de Boer-Bergsma JJ; Eggen BJL; Baron W
    J Neuroinflammation; 2020 Dec; 17(1):373. PubMed ID: 33308248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative injury in multiple sclerosis cerebellar grey matter.
    Kemp K; Redondo J; Hares K; Rice C; Scolding N; Wilkins A
    Brain Res; 2016 Jul; 1642():452-460. PubMed ID: 27086975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.
    Chomyk A; Kucinski R; Kim J; Christie E; Cyncynatus K; Gossman Z; Chen Z; Richardson B; Cameron M; Turner T; Dutta R; Trapp B
    Ann Neurol; 2024 May; 95(5):907-916. PubMed ID: 38345145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin development in cerebral gray and white matter during adolescence and late childhood.
    Corrigan NM; Yarnykh VL; Hippe DS; Owen JP; Huber E; Zhao TC; Kuhl PK
    Neuroimage; 2021 Feb; 227():117678. PubMed ID: 33359342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray and white matter are both affected in classical galactosemia: An explorative study on the association between neuroimaging and clinical outcome.
    Welsink-Karssies MM; Schrantee A; Caan MWA; Hollak CEM; Janssen MCH; Oussoren E; de Vries MC; Roosendaal SD; Engelen M; Bosch AM
    Mol Genet Metab; 2020 Dec; 131(4):370-379. PubMed ID: 33199205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic correlates of the magnetization transfer ratio in multiple sclerosis.
    Moccia M; van de Pavert S; Eshaghi A; Haider L; Pichat J; Yiannakas M; Ourselin S; Wang Y; Wheeler-Kingshott C; Thompson A; Barkhof F; Ciccarelli O
    Neurology; 2020 Dec; 95(22):e2965-e2976. PubMed ID: 32938787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter aging drives microglial diversity.
    Safaiyan S; Besson-Girard S; Kaya T; Cantuti-Castelvetri L; Liu L; Ji H; Schifferer M; Gouna G; Usifo F; Kannaiyan N; Fitzner D; Xiang X; Rossner MJ; Brendel M; Gokce O; Simons M
    Neuron; 2021 Apr; 109(7):1100-1117.e10. PubMed ID: 33606969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.
    Prins M; Dutta R; Baselmans B; Brevé JJ; Bol JG; Deckard SA; van der Valk P; Amor S; Trapp BD; de Vries HE; Drukarch B; van Dam AM
    Acta Neuropathol Commun; 2014 Aug; 2():98. PubMed ID: 25149422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
    Lee H; Nakamura K; Narayanan S; Brown R; Chen J; Atkins HL; Freedman MS; Arnold DL
    Mult Scler; 2018 Jul; 24(8):1055-1066. PubMed ID: 28617152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes.
    van der Poel M; Ulas T; Mizee MR; Hsiao CC; Miedema SSM; Adelia ; Schuurman KG; Helder B; Tas SW; Schultze JL; Hamann J; Huitinga I
    Nat Commun; 2019 Mar; 10(1):1139. PubMed ID: 30867424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gray matter lesions and cognitive impairment in multiple sclerosis].
    Kawachi I; Saji E; Nishizawa M
    Rinsho Shinkeigaku; 2014; 54(12):1060-2. PubMed ID: 25672709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
    Futatsuya K; Kakeda S; Yoneda T; Ueda I; Watanabe K; Moriya J; Murakami Y; Ide S; Ogasawara A; Ohnari N; Okada K; Adachi H; Korogi Y
    Magn Reson Med Sci; 2016 Oct; 15(4):349-354. PubMed ID: 26841855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter astrocytes in health and disease.
    Lundgaard I; Osório MJ; Kress BT; Sanggaard S; Nedergaard M
    Neuroscience; 2014 Sep; 276():161-73. PubMed ID: 24231735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.